How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023

• Main Authors: Mojca Maticic (Author), J. Cernosa (Author), C. Loboda (Author), J. Tamse (Author), R. Rigoni (Author), E. Duffell (Author), I. Indave (Author), R. Zimmermann (Author), L. Darragh (Author), J. Moura (Author), A. Leicht (Author), T. Windelinckx (Author), M. Jauffret-Roustide (Author), K. Schiffer (Author), T. Tammi (Author)
• Format: Book
• Published: BMC, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background With the advent of direct acting antivirals (DAAs) the World Health Organisation (WHO) adopted global strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Europe, people who inject drugs (PWID) account for the majority of new cases, however testing and treatment re...